ADESSO SE (ADN1.DE) Fundamental Analysis & Valuation
FRA:ADN1 • DE000A0Z23Q5
Current stock price
58.5 EUR
+0.3 (+0.52%)
Last:
This ADN1.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. ADN1.DE Profitability Analysis
1.1 Basic Checks
- ADN1 had positive earnings in the past year.
- In the past year ADN1 had a positive cash flow from operations.
- In the past 5 years ADN1 has always been profitable.
- ADN1 had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
- ADN1 has a Return On Assets (3.14%) which is in line with its industry peers.
- ADN1 has a better Return On Equity (14.06%) than 67.14% of its industry peers.
- The Return On Invested Capital of ADN1 (7.75%) is comparable to the rest of the industry.
- Measured over the past 3 years, the Average Return On Invested Capital for ADN1 is significantly below the industry average of 11.52%.
- The 3 year average ROIC (3.93%) for ADN1 is below the current ROIC(7.75%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.14% | ||
| ROE | 14.06% | ||
| ROIC | 7.75% |
ROA(3y)1.19%
ROA(5y)3.29%
ROE(3y)5.14%
ROE(5y)10.94%
ROIC(3y)3.93%
ROIC(5y)4.86%
1.3 Margins
- The Profit Margin of ADN1 (1.22%) is worse than 64.29% of its industry peers.
- In the last couple of years the Profit Margin of ADN1 has declined.
- ADN1 has a Operating Margin of 3.41%. This is in the lower half of the industry: ADN1 underperforms 64.29% of its industry peers.
- In the last couple of years the Operating Margin of ADN1 has declined.
- The Gross Margin of ADN1 (85.44%) is better than 78.57% of its industry peers.
- ADN1's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 3.41% | ||
| PM (TTM) | 1.22% | ||
| GM | 85.44% |
OM growth 3Y-6.08%
OM growth 5Y-12.73%
PM growth 3Y-26.96%
PM growth 5Y-20.92%
GM growth 3Y0.18%
GM growth 5Y-0.58%
2. ADN1.DE Health Analysis
2.1 Basic Checks
- ADN1 has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
- The number of shares outstanding for ADN1 has been reduced compared to 1 year ago.
- The number of shares outstanding for ADN1 has been increased compared to 5 years ago.
- The debt/assets ratio for ADN1 is higher compared to a year ago.
2.2 Solvency
- ADN1 has an Altman-Z score of 3.60. This indicates that ADN1 is financially healthy and has little risk of bankruptcy at the moment.
- The Altman-Z score of ADN1 (3.60) is better than 81.43% of its industry peers.
- ADN1 has a debt to FCF ratio of 8.04. This is a slightly negative value and a sign of low solvency as ADN1 would need 8.04 years to pay back of all of its debts.
- With a Debt to FCF ratio value of 8.04, ADN1 is not doing good in the industry: 65.71% of the companies in the same industry are doing better.
- ADN1 has a Debt/Equity ratio of 1.57. This is a high value indicating a heavy dependency on external financing.
- ADN1 has a Debt to Equity ratio of 1.57. This is in the lower half of the industry: ADN1 underperforms 78.57% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.57 | ||
| Debt/FCF | 8.04 | ||
| Altman-Z | 3.6 |
ROIC/WACC1.51
WACC5.12%
2.3 Liquidity
- A Current Ratio of 1.26 indicates that ADN1 should not have too much problems paying its short term obligations.
- The Current ratio of ADN1 (1.26) is comparable to the rest of the industry.
- ADN1 has a Quick Ratio of 1.26. This is a normal value and indicates that ADN1 is financially healthy and should not expect problems in meeting its short term obligations.
- ADN1 has a Quick ratio (1.26) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.26 | ||
| Quick Ratio | 1.26 |
3. ADN1.DE Growth Analysis
3.1 Past
- ADN1 shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 67.67%, which is quite impressive.
- The Earnings Per Share has been decreasing by -3.89% on average over the past years.
- The Revenue has grown by 12.83% in the past year. This is quite good.
- ADN1 shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 22.87% yearly.
EPS 1Y (TTM)67.67%
EPS 3Y-14.06%
EPS 5Y-3.89%
EPS Q2Q%32.01%
Revenue 1Y (TTM)12.83%
Revenue growth 3Y17.64%
Revenue growth 5Y22.87%
Sales Q2Q%125.29%
3.2 Future
- The Earnings Per Share is expected to grow by 28.90% on average over the next years. This is a very strong growth
- The Revenue is expected to grow by 9.13% on average over the next years. This is quite good.
EPS Next Y59.05%
EPS Next 2Y47.94%
EPS Next 3Y32.87%
EPS Next 5Y28.9%
Revenue Next Year11.43%
Revenue Next 2Y10.78%
Revenue Next 3Y10.56%
Revenue Next 5Y9.13%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. ADN1.DE Valuation Analysis
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 14.37, ADN1 is valued correctly.
- Compared to the rest of the industry, the Price/Earnings ratio of ADN1 indicates a somewhat cheap valuation: ADN1 is cheaper than 71.43% of the companies listed in the same industry.
- The average S&P500 Price/Earnings ratio is at 26.54. ADN1 is valued slightly cheaper when compared to this.
- The Price/Forward Earnings ratio is 11.22, which indicates a very decent valuation of ADN1.
- Based on the Price/Forward Earnings ratio, ADN1 is valued a bit cheaper than the industry average as 71.43% of the companies are valued more expensively.
- The average S&P500 Price/Forward Earnings ratio is at 21.68. ADN1 is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.37 | ||
| Fwd PE | 11.22 |
4.2 Price Multiples
- ADN1's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. ADN1 is cheaper than 84.29% of the companies in the same industry.
- Based on the Price/Free Cash Flow ratio, ADN1 is valued a bit cheaper than 70.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 8.85 | ||
| EV/EBITDA | 4.28 |
4.3 Compensation for Growth
- The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- A more expensive valuation may be justified as ADN1's earnings are expected to grow with 32.87% in the coming years.
PEG (NY)0.24
PEG (5Y)N/A
EPS Next 2Y47.94%
EPS Next 3Y32.87%
5. ADN1.DE Dividend Analysis
5.1 Amount
- With a Yearly Dividend Yield of 1.32%, ADN1 has a reasonable but not impressive dividend return.
- The stock price of ADN1 dropped by -28.04% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
- ADN1's Dividend Yield is comparable with the industry average which is at 2.71.
- Compared to the average S&P500 Dividend Yield of 1.82, ADN1 is paying slightly less dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.32% |
5.2 History
- On average, the dividend of ADN1 grows each year by 10.98%, which is quite nice.
Dividend Growth(5Y)10.98%
Div Incr Years1
Div Non Decr Years7
5.3 Sustainability
- 19.02% of the earnings are spent on dividend by ADN1. This is a low number and sustainable payout ratio.
- The dividend of ADN1 is growing, but earnings are growing more, so the dividend growth is sustainable.
DP19.02%
EPS Next 2Y47.94%
EPS Next 3Y32.87%
ADN1.DE Fundamentals: All Metrics, Ratios and Statistics
FRA:ADN1 (4/29/2026, 7:00:00 PM)
58.5
+0.3 (+0.52%)
Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Industry Strength15.54
Industry Growth46
Earnings (Last)03-31 2026-03-31/amc
Earnings (Next)05-11 2026-05-11
Inst Owners19.56%
Inst Owner ChangeN/A
Ins Owners50.29%
Ins Owner ChangeN/A
Market Cap382.00M
Revenue(TTM)2.19B
Net Income(TTM)26.67M
Analysts83.33
Price Target116.45 (99.06%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.32% |
Yearly Dividend0.79
Dividend Growth(5Y)10.98%
DP19.02%
Div Incr Years1
Div Non Decr Years7
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-10.69%
PT rev (3m)-10.69%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-3.51%
EPS NY rev (3m)-3.77%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.86%
Revenue NY rev (3m)1.92%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.37 | ||
| Fwd PE | 11.22 | ||
| P/S | 0.17 | ||
| P/FCF | 8.85 | ||
| P/OCF | 4.46 | ||
| P/B | 2.01 | ||
| P/tB | 14.52 | ||
| EV/EBITDA | 4.28 |
EPS(TTM)4.07
EY6.96%
EPS(NY)5.21
Fwd EY8.91%
FCF(TTM)6.61
FCFY11.3%
OCF(TTM)13.1
OCFY22.4%
SpS335.95
BVpS29.05
TBVpS4.03
PEG (NY)0.24
PEG (5Y)N/A
Graham Number51.578 (-11.83%)
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.14% | ||
| ROE | 14.06% | ||
| ROCE | 14.37% | ||
| ROIC | 7.75% | ||
| ROICexc | 9.35% | ||
| ROICexgc | 15.05% | ||
| OM | 3.41% | ||
| PM (TTM) | 1.22% | ||
| GM | 85.44% | ||
| FCFM | 1.97% |
ROA(3y)1.19%
ROA(5y)3.29%
ROE(3y)5.14%
ROE(5y)10.94%
ROIC(3y)3.93%
ROIC(5y)4.86%
ROICexc(3y)4.85%
ROICexc(5y)6.34%
ROICexgc(3y)7.73%
ROICexgc(5y)10.11%
ROCE(3y)7.28%
ROCE(5y)9.01%
ROICexgc growth 3Y-3.69%
ROICexgc growth 5Y-13.49%
ROICexc growth 3Y-1.87%
ROICexc growth 5Y-10.76%
OM growth 3Y-6.08%
OM growth 5Y-12.73%
PM growth 3Y-26.96%
PM growth 5Y-20.92%
GM growth 3Y0.18%
GM growth 5Y-0.58%
F-Score7
Asset Turnover2.59
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.57 | ||
| Debt/FCF | 8.04 | ||
| Debt/EBITDA | 2.02 | ||
| Cap/Depr | 58.09% | ||
| Cap/Sales | 1.93% | ||
| Interest Coverage | 6.36 | ||
| Cash Conversion | 57.86% | ||
| Profit Quality | 161.81% | ||
| Current Ratio | 1.26 | ||
| Quick Ratio | 1.26 | ||
| Altman-Z | 3.6 |
F-Score7
WACC5.12%
ROIC/WACC1.51
Cap/Depr(3y)53.58%
Cap/Depr(5y)53.05%
Cap/Sales(3y)2.72%
Cap/Sales(5y)2.71%
Profit Quality(3y)855.55%
Profit Quality(5y)534.25%
High Growth Momentum
Growth
EPS 1Y (TTM)67.67%
EPS 3Y-14.06%
EPS 5Y-3.89%
EPS Q2Q%32.01%
EPS Next Y59.05%
EPS Next 2Y47.94%
EPS Next 3Y32.87%
EPS Next 5Y28.9%
Revenue 1Y (TTM)12.83%
Revenue growth 3Y17.64%
Revenue growth 5Y22.87%
Sales Q2Q%125.29%
Revenue Next Year11.43%
Revenue Next 2Y10.78%
Revenue Next 3Y10.56%
Revenue Next 5Y9.13%
EBIT growth 1Y30.75%
EBIT growth 3Y10.49%
EBIT growth 5Y7.24%
EBIT Next Year207.93%
EBIT Next 3Y55.24%
EBIT Next 5Y33.1%
FCF growth 1Y-47%
FCF growth 3Y52.7%
FCF growth 5Y-4.44%
OCF growth 1Y-22.61%
OCF growth 3Y33.36%
OCF growth 5Y5.66%
ADESSO SE / ADN1.DE Fundamental Analysis FAQ
What is the ChartMill fundamental rating of ADESSO SE (ADN1.DE) stock?
ChartMill assigns a fundamental rating of 5 / 10 to ADN1.DE.
Can you provide the valuation status for ADESSO SE?
ChartMill assigns a valuation rating of 7 / 10 to ADESSO SE (ADN1.DE). This can be considered as Undervalued.
How profitable is ADESSO SE (ADN1.DE) stock?
ADESSO SE (ADN1.DE) has a profitability rating of 4 / 10.
What is the financial health of ADESSO SE (ADN1.DE) stock?
The financial health rating of ADESSO SE (ADN1.DE) is 4 / 10.
Can you provide the dividend sustainability for ADN1 stock?
The dividend rating of ADESSO SE (ADN1.DE) is 5 / 10 and the dividend payout ratio is 19.02%.